X

AggregoTV

AggregoTV

`
ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.

12/17/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020

Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

12/11/2020
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020
Pancreatic Cancer and Immunotherapy with Dr. Elizabeth M. Jaffee

Join Dr. Elizabeth Jaffee of the Bloomberg~Kimmel Institute for Cancer Immunotherapy for a Q&A discussion about immunotherapies in clinical trials for pancreatic cancer.

12/11/2020
Kidney Cancer and Immunotherapy with Dr. Saby George

Dr. Saby George of Roswell Park Comprehensive Cancer Center leads a Q&A about combination therapies, clinical trials, and new promise in kidney cancer.

12/11/2020
Bladder Cancer and Immunotherapy with Dr. Terence Friedlander

Dr. Terence Friedlander of UCSF Helen Diller Family Comprehensive Cancer Center discusses the potential to further improve outcomes for patients with bladder cancer.

12/11/2020
Head and Neck Cancer and Immunotherapy with Dr. Trisha Wise-Draper

New checkpoint inhibitors and other immunotherapies for head and neck cancer with oncologist Dr. Trisha Wise-Draper of the University of Cincinnati Cancer Center Clinical Trials Office.

12/11/2020
ASH 2020: Highlights for GvHD

GvHD Hub Chair Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR, provides the highlights for GvHD from the 62nd ASH Annual Meeting and Exposition.

12/14/2020
Alfred Garfall: Evaluating Teclistamab in Relapsed and/or Refractory Multiple Myeloma

Dr. Alfred Garfall discusses the evaluation of teclistamab in relapsed and/or refractory multiple myeloma.

12/05/2020
Jacqueline Garcia: Evaluating Venetoclax Plus Azacitidine in Patients with High-Risk MDS

Dr. Jacqueline Garcia discusses evaluating venetoclax plus azacitidine in patients with high-risk MDS.

12/07/2020
ESMO Immuno-Oncology Virtual Congress 2020 - Prof. Thomas Powles

Prof. Thomas Powles on new data at ESMO Immuno-Oncology Virtual Congress 2020​. 

12/01/2020
Treatment | ASH Clinical Practice Guidelines on Venous Thromboembolism (VTE)

Thomas L. Ortel, MD, PhD discusses the treatment chapter of the ASH Clinical Practice Guidelines on Venous Thromboembolism.

10/01/2020
Cancer and the Microbiome: How Bacteria Influence Immunotherapy with Dr. Gregory Sonnenberg

CRI LJO STAR Dr. Gregory Sonnenberg discusses the influence of the microbiome in cancer.

11/04/2020
Ovarian Cancer Immunotherapy with Dr. Kunle Odunsi

Dr. Kunle Odunsi discusses the latest breakthroughs and future promise of immunotherapy for ovarian cancer patients.

10/09/2020
Breast Cancer Immunotherapy with Dr. Sylvia Adams and Victor Ty, BSN, RN

Dr. Sylvia Adams and Victor Ty lead a discussion on the latest immunotherapies available for breast cancer patients.

10/09/2020
Melanoma Immunotherapy with Dr. Jedd Wolchok

Dr. Jedd Wolchok leads a discussion on the latest immunotherapy research for melanoma.

10/09/2020
ESMO Perspectives Video Editorial: Cancer screenings in the COVID-19 era

In his video editorial from the latest edition of the ESMO Perspectives, Dr Stefan Zimmerman, CHUV, Lausanne, Switzerland, explains why there will be a very steep price to pay later down the line.<

10/29/2020
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

10/23/2020
ESMO Immuno-Oncology Virtual Congress 2020​​

Prof. Kevin Harrington provides additional enticements not to miss ESMO Immuno-Oncology Virtual Congress 2020​​.

11/18/2020

source list reference

#7d60d9
#2694a4
#85eb24
#352625
#4d4537
#d2093c
#8e3f1c
#76b6c3
#bfcfc8
#c61417
#67e25b
#efef71
#42fc9a
#cc529a
#c59445
#c8cc0c
#e8085a
#97d1a0
#b61f77
#a153ac
#e7f6e3
#9a8c2c
#a9c507
#990677
#4a7bab
#89f67c
#49a21d
#2c990a
#d7da81
#575662
#49cde9
#c20fce
#d95d39